Eli Lilly has issued a `Dear Healthcare Professional' letter to advise of a new warning on the US Xigris [drotrecogin alfa] label
Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1044-1045, 2005-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
